Cargando…

IgM exacerbates glomerular disease progression in complement induced glomerulopathy

While glomerular IgM deposition occurs in a variety of glomerular diseases the mechanism of deposition and its clinical significance remain controversial. Some have theorized IgM becomes passively trapped in areas of glomerulosclerosis. However, recent studies found that IgM specifically binds damag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panzer, Sarah E., Laskowski, Jennifer, Renner, Brandon, Kulik, Liudmila, Ljubanovic, Danica, Huber, Kendra M., Zhong, Weixiong, Pickering, Matthew C., Holers, V. Michael, Thurman, Joshua M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556608/ https://www.ncbi.nlm.nih.gov/pubmed/25945405 http://dx.doi.org/10.1038/ki.2015.120

Ejemplares similares

Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement
por: Narang, Aarti, et al.
Publicado: (2017)

Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy
por: Panzer, Sarah E., et al.
Publicado: (2019)

Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions
por: Hannan, Jonathan P., et al.
Publicado: (2016)

Glomerular Complement Factor H–Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2019)

C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice
por: Banda, Nirmal K., et al.
Publicado: (2020)

Resistant and Relapsing Collapsing Glomerulopathy Successfully Treated with Rituximab—A Case Report
por: Zagorec, Nikola, et al.
Publicado: (2022)

IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis
por: Pačić, Arijana, et al.
Publicado: (2017)

Unusual cause of glomerular deposition disease: Collagenofibrotic glomerulopathy
por: Nimmagadda, S., et al.
Publicado: (2017)

Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease
por: Jalal, Diana, et al.
Publicado: (2018)

Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy
por: Barbour, Thomas D., et al.
Publicado: (2016)

Fibronectin Glomerulopathy: A Rare Autosomal Dominant Glomerular Disease
por: Wu, Jing, et al.
Publicado: (2017)

Immunotactoid Glomerulopathy: A Rare Glomerular Disease Case Study
por: Karanfilovski, Vlatko, et al.
Publicado: (2023)

Complement and Cancer—A Dysfunctional Relationship?
por: Thurman, Joshua M., et al.
Publicado: (2020)

Evaluating the B-cell C3d:CR2 innate-adaptive immune interaction as a therapeutic target in lupus
por: Holers, VM, et al.
Publicado: (2012)

An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy
por: Nichols, Eva-Maria, et al.
Publicado: (2015)

Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases
por: Dixon, Bradley P., et al.
Publicado: (2023)

Transplant Glomerulopathy With Glomerular C3 Deposits: Why the Worse Outcome?
por: Yamashita, Michifumi, et al.
Publicado: (2019)

A Case of Glomerulopathy Associated With Monoclonal Glomerular Basement Membrane Antibody
por: Bonilla, Marco, et al.
Publicado: (2021)

A CHILD WITH DENSE DEPOSIT DISEASE AND DECREASED CLASSIC COMPLEMENT PATHWAY ACTIVITY
por: Trutin, Ivana, et al.
Publicado: (2021)

Complement and autoimmunity: new insights into old questions
por: Holers, VM, et al.
Publicado: (2004)

Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003)

Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21)
por: Pappworth, Isabel Y., et al.
Publicado: (2009)

Clinical relevance of glomerular IgM deposition in patients with lupus nephritis
por: Wang, Fengmei, et al.
Publicado: (2021)

Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015
por: Noris, Marina, et al.
Publicado: (2015)

C3 glomerulopathy: consensus report
por: Pickering, Matthew C, et al.
Publicado: (2013)

PULMONARY HEMORRHAGE AND CRESCENTIC GLOMERULONEPHRITIS IN A PATIENT WITH SEROPOSITIVE ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE AND ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES
por: Sreter, Katherina Bernadette, et al.
Publicado: (2022)

Complement activity is regulated in C3 glomerulopathy by IgG–factor H fusion proteins with and without properdin targeting domains
por: Gilmore, Alyssa C., et al.
Publicado: (2021)

Fibronectin Glomerulopathy Confused with Glomerular Endothelial Injury in a Patient with Takotsubo Cardiomyopathy
por: Azegami, Tatsuhiko, et al.
Publicado: (2021)

Update on C3 glomerulopathy
por: Barbour, Thomas D., et al.
Publicado: (2016)

Complement in glomerular injury
por: Berger, Stefan P., et al.
Publicado: (2007)

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
por: Girardi, Guillermina, et al.
Publicado: (2006)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Polyclonal Immunotactoid Glomerulopathy Associated with Monoclonal Gammopathy of IgM Type and Underlying Plasmacellular Disease: Successful Treatment with Rituximab Alone
por: Neukirchen, Wolfgang, et al.
Publicado: (2022)

Glomerular C4d Staining Does Not Exclude a C3 Glomerulopathy
por: Singh, Geetika, et al.
Publicado: (2019)

Glomerular C4d Immunoperoxidase in Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy
por: Nankivell, Brian J., et al.
Publicado: (2022)

Recent insights into C3 glomerulopathy
por: Barbour, Thomas D., et al.
Publicado: (2013)

IgM cleavage by Streptococcus suis reduces IgM bound to the bacterial surface and is a novel complement evasion mechanism
por: Rungelrath, Viktoria, et al.
Publicado: (2018)

Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b
por: Sharp, Thomas H., et al.
Publicado: (2019)

Complement activation is required for IgM-mediated enhancement of the antibody response
Publicado: (1988)

Contribution of classical complement activation and IgM to the control of Rickettsia infection
por: Dahmani, Mustapha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jh1g4d0pgod1k5mqq9tc9vbtr1